Valuation: Active Biotech AB

Market Cap 140M 14.74M 12.62M 11.78M 10.81M 20.31M 1.41B 20.71M 54.46M 707M 55.35M 54.15M 2.34B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 140M 14.74M 12.62M 11.78M 10.81M 20.31M 1.41B 20.71M 54.46M 707M 55.35M 54.15M 2.34B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
83.01%
Yield 2026 *
-
Yield 2027 * -
1 week+2.71%
Current month+2.71%
1 month+2.91%
3 months-26.18%
6 months+12.77%
Current year+15.22%
1 week 5.08
Extreme 5.08
5.69
1 month 5.01
Extreme 5.01
5.69
3 years 3.7
Extreme 3.7
52.95
5 years 3.7
Extreme 3.7
52.95
10 years 3.7
Extreme 3.7
427.11
Manager TitleAgeSince
Chief Executive Officer 64 2017-06-30
Director of Finance/CFO 75 1999-12-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 70 2011-04-06
Chairman 61 2019-05-22
Director/Board Member 76 2019-05-22
Date Insider Type Main position Quantity % Market Cap.
1/25/21 Buy

Director

24,261 -
1/25/21 Buy

Director

525,000 -
1/25/21 Buy

Director

935,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%+0.77%-62.68%-80.72% 14.74M
+2.38%+3.43%+82.88%+115.89% 73.96B
-0.36%+20.79%+53.12%+93.38% 64.66B
-4.27%-0.99%-3.38%+475.61% 27.32B
-1.97%+20.38%-0.37%+0.48% 27.86B
+2.74%+12.98%+62.84%+28.14% 25.97B
-0.51%+5.13%+35.39%-14.59% 19.98B
-1.79%-4.84%+239.54%+414.48% 17.84B
+0.94%+3.36%+18.55%+532.94% 16.24B
-1.29%+6.09%+41.81%+154.45% 13.3B
Average -0.46%+6.18%+46.77%+172.01% 31.9B
Weighted average by Cap. +0.03%+8.21%+58.97%+160.75%

Financials

2026 *2027 *
Net sales - -
Net income -33.2M -3.5M -3M -2.8M -2.57M -4.83M -335M -4.92M -12.94M -168M -13.15M -12.87M -556M 18.2M 1.92M 1.64M 1.53M 1.41M 2.65M 184M 2.7M 7.09M 92.09M 7.21M 7.05M 305M
Net Debt - -
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
-
Date Price Change Volume
26-08-21 SEK 5.230 -1.32% 14,514
26-08-20 SEK 5.300 +2.71% 112,816
26-08-19 SEK 5.160 +0.19% 49,406
26-08-18 SEK 5.150 +0.98% 159,187
26-08-17 SEK 5.100 -1.73% 44,048
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Net sales - Rate of surprise